Evidence map›Paper›PMID 35931874›Full record

ReviewMolecular biology reports2022

The cell cycle, cancer development and therapy.

Elaheh Jamasbi, Mona Hamelian, Mohammed Akhter Hossain, Kambiz Varmira

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular biology reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed
11.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed, 101 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Chromatin regulatorsChinese journal of cancer research = Chung-kuo yen cheng yen chiu · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Elaheh JamasbiResearch Center of Oils and Fats (RCOF), Kermanshah University of Medical Sciences, Kermanshah, Iran.
Mona HamelianResearch Center of Oils and Fats (RCOF), Kermanshah University of Medical Sciences, Kermanshah, Iran.
Mohammed Akhter HossainThe Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, VIC, 3010, Australia.
Kambiz VarmiraResearch Center of Oils and Fats (RCOF), Kermanshah University of Medical Sciences, Kermanshah, Iran. varmira@gmail.com.
Kermanshah University of Medical Sciences · IRUniversity of Melbourne · AU

Funding

Kermanshah University of Medical Sciences 96494
6 · The paper itself

Abstract

The process of cell division plays a vital role in cancer progression. Cell proliferation and error-free chromosomes segregation during mitosis are central events in life cycle. Mistakes during cell division generate changes in chromosome content and alter the balances of chromosomes number. Any defects in expression of TIF1 family proteins, SAC proteins network, mitotic checkpoint proteins involved in chromosome mis-segregation and cancer development. Here we discuss the function of organelles deal with the chromosome segregation machinery, proteins and correction mechanisms involved in the accurate chromosome segregation during mitosis.

Indexed as

Chromosome SegregationNeoplasmsCell CycleCell Cycle ProteinsHumansKinetochoresMitosisM Phase Cell Cycle CheckpointsCell Cycle ProteinsCancerCell cycleMitosis cell divisionProteins

Identifiers

PMID35931874
OpenAlexW4290080792

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.